Intermediate-size IND for Treatment of Patients With Advanced Cancer Using T Cells Engineered to Express TCR Targeting Mutant KRAS
Clinical trial NCT07614048 · AVAILABLE
Trial details
- NCT number
- NCT07614048
- Sponsor
- Providence Health & Services
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.